| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Endonovo Therapeutics, Inc. (ENDV) has 0 insiders with recent SEC Form 4 filings, including 51 buys and 0 sells. ENDV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2020 | Collier Alan Brian | CEO | Buy | 400 | $0.10 | $40.98 | +0.5% | |
| Feb 22, 2020 | Collier Alan Brian | Director | Buy | 100 | $0.96 | $96.49 | +0.4% | |
| Jan 2, 2020 | Collier Alan Brian | CEO | Buy | 200 | $2.00 | $400.00 | - | |
| Dec 20, 2019 | Collier Alan Brian | CEO | Buy | 5,700 | $0.00 | $13.39 | - | |
| Dec 5, 2019 | Collier Alan Brian | CEO | Buy | 15,000 | $0.00 | $46.30 | - | |
| Nov 22, 2019 | Collier Alan Brian | CEO | Buy | 3,000 | $0.00 | $11.30 | - | |
| Nov 11, 2019 | Collier Alan Brian | CEO | Buy | 2,000 | $0.01 | $14.20 | - | |
| Nov 4, 2019 | Collier Alan Brian | CEO | Buy | 51,200 | $0.01 | $269.45 | - | |
| Oct 15, 2019 | Collier Alan Brian | CEO | Buy | 10,400 | $0.01 | $106.96 | - | |
| Sep 30, 2019 | Collier Alan Brian | CEO | Buy | 600 | $0.01 | $5.50 | - |